Antitrust Antitrust

Gilead, Teva get jury for US antitrust trial over HIV medication; judge orders C-suite executives to show up tomorrow

By Michael Acton
  • 24 May 2023 23:10
  • 24 May 2023 23:10
Gilead and Teva have had a jury selected in San Francisco today in a trial over their alleged pay-for-delay scheme for HIV drugs.

US District Judge Edward Chen ordered C-suite executives from the two pharmaceutical companies, as well as representatives of clients on the plaintiff side, to turn up in court

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Michael Acton

Senior Correspondent

Michael is a senior correspondent for MLex in San Francisco, where he moved in 2020 after working in our Brussels bureau. Before joining MLex, he reported on EU politics as the Financial Times’ Nico Colchester Fellow in Brussels. Michael has a degree in International Relations and Politics from the University of Cambridge, and a degree in History and French from University College London and Paris IV Sorbonne.

Discover MLex

Stay on top of global regulatory developments

Latest News